Insider Trades
| Actor | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
Duggan Robert WDirector, 10 Percent Owner, Officer: Co-Chief Executive Officer --100k shares BuyJun 4, 2026 $1.5M100k shares $14.60 $17.36 | |||||
News
businesswire.comSummit Therapeutics Announces Proposed Public Offering of Common Stockbusinesswire.comJun 9
seekingalpha.comSummit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 8
247wallst.comMizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech247wallst.comJun 7
wsj.comThe Era of the One-Size-Fits-All Cancer Drug Is Endingwsj.comJun 6
businesswire.comSummit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conferencebusinesswire.comJun 4